Literature DB >> 36033204

Postoperative Anterior Cruciate Ligament Reconstruction Quadricep and Patella Tendon Rupture, Infection, and Lysis of Adhesions Decreased Despite Changing Graft Trends Over the Past Decade.

Hayden P Baker1, Sarah Bhattacharjee1, Charles Poff1, Collin Bartolotta1, Aravind Athiviraham1.   

Abstract

Purpose: To investigate recent trends in postoperative complications following anterior cruciate ligament (ACL) reconstruction.
Methods: Patients who underwent ACL reconstruction surgery were identified in a national insurance database and separated into 2 cohorts based on the date of their initial surgery comprising the years 2010 to 2012 and 2016 to 2018, respectively. Patients were matched 1:1 based on comorbidities and Elixhauser Comorbidity Index. All patients were assessed for postoperative complications within 18 months of surgery. Rate of complication was compared between cohorts.
Results: Overall, the all-cause complication rate was 2%. There were significantly more quadriceps tendon rupture, patella tendon rupture, lysis of adhesion, and infection in the early cohort. There were significantly more instances of deep vein thrombosis in the late cohort. We found no significant difference in manipulations under anesthesia between the 2 cohorts. Conclusions: Patients who underwent surgery in the late cohort had lower rates of postoperative complications, except for deep vein thrombosis. The rate of postoperative quadriceps tendon rupture decreased despite considerable increase in the use of quadriceps tendon autograft. Clinical Relevance: As there has been an increased use of quadriceps tendon autografts, but little is known about the postoperative complications after ACL reconstruction with these grafts. This information has the potential to improve patient outcomes.
© 2022 The Authors.

Entities:  

Year:  2022        PMID: 36033204      PMCID: PMC9402459          DOI: 10.1016/j.asmr.2022.04.033

Source DB:  PubMed          Journal:  Arthrosc Sports Med Rehabil        ISSN: 2666-061X


Anterior cruciate ligament (ACL) tears are one of the most common orthopaedic injuries sustained in the United States, with an annual incidence of 68.6 per 100,000 person-years. ACL reconstruction is most commonly performed using either bone–patellar tendon–bone (BPTB) or hamstring tendon (HT) autograft; however, use of quadriceps tendon (QT) autograft has increased over the past decade., Reported advantages of QT autograft include ease of harvest, large cross-sectional area, and relatively low donor-site morbidity., In less than 5 years, the rate of QT autograft use increased 4-fold from 2.5% in 2010 to 11% in 2014. A recent survey of the ACL study group demonstrated that the popularity of QT autograft has continued to increase from 2014 to present. It is also known that QT autograft is becoming increasingly used in revision ACL reconstruction, possibly due to decreased failure rates relative to HT autograft. As QT use has increased since 2010, so too has its inclusion in orthopaedic literature. A systematic review by Heffron et al. showed that since its introduction to orthopaedic literature in 1979, 30% of all publications on QT for ACL reconstruction were published between 2016 and 2019. BPTB and HT are traditionally thought to be the standard choices for ACL reconstruction autograft; however, recent data have shown that outcomes for QT versus BPTB and HT are, at least, equivocal. Cavaignac et al. found that Lysholm, Knee Injury and Osteoarthritis Outcome Score, and Knee Injury and Osteoarthritis Outcome Score Sport scores were significantly improved in patients grafted with QT versus HT. In the same study, indices of stability such as side-to-side difference and presence of negative Lachman test were improved in the QT group. Recent systematic reviews have gone on to demonstrate no significant differences in patient-reported outcomes, stability indices, and graft failure rates in patients treated with QT compared with both BPTB and HT. In fact, QT was shown to have lower rates of anterior knee pain and donor-site pain than BPTB., The purpose of this study was to investigate recent trends in postoperative complications following ACL reconstruction. Our null hypothesis was that there would be no significant difference in the rate of postoperative complications between the 2 cohorts despite a significant increase in QT use for ACL reconstruction since 2010.

Methods

Database

This retrospective study was conducted using PearlDiver, a national insurance claims database widely used in orthopaedic literature. PearlDiver comprises more than 93 million individual patient records spanning 2010 to 2020. These records are searchable using physician billing codes including International Classification of Diseases, Revisions 9 and 10 (ICD-9/ICD-10) diagnostic codes, Current Procedural Terminology (CPT) procedural codes, and drug codes.

Patient Selection

All patients who underwent an ACL reconstruction were identified in the database via CPT 29888 and sorted based on the date of their surgery into 2 cohorts: an early cohort comprising the years of 2010 to 2012 and a late cohort from 2016 to 2018. As we were interested in comparing their postoperative complications, all patients were required to be continuously active for 18 months in the database following the initial date of surgery. We matched patient comorbidities 1:1 based on age, sex, tobacco use, obesity, diabetes, and Elixhauser Comorbidity Index between the 2 cohorts. Postoperative surgical complications included QT rupture, patellar tendon rupture, manipulation under anesthesia, return to the operating room for lysis of adhesions, infection, and deep vein thrombosis (DVT). The surgical complications rates were defined using CPT and ICD-9 codes.

Statistical Analysis

We used Pearson χ2 analysis to assess the univariate difference in rates of surgical complications between the early and late cohorts. The Student t-test was used to compare continuous variables. All tests were conducted at an alpha level of 0.05. For complication outcomes that were statistically significant, a multivariate logistic regression was used to account for potential confounding from the comorbidities and demographic factors of age, sex, tobacco use, obesity, and diabetes. The adjusted odds ratios (ORs) and confidence intervals (CIs) were determined from the multivariate analysis. Statistical analysis was done using the R statistical package available through PearlDiver.

Results

A total of 80,376 patients who underwent ACL reconstruction were identified, 46,024 of whom underwent surgery in the years 2010 to 2012, and 34,352 of whom underwent surgery in the years 2016 to 2018 with 18 months of follow-up. After matching patient comorbidities and Elixhauser Comorbidity Index 1:1, 27,057 patients remained in each cohort (Table 1). Overall, the all-cause complication rate was 2%. There was significantly more QT rupture, patella tendon rupture, lysis of adhesion, and infection in the early cohort (Table 2). However, there was significantly more DVTs in the late cohort. We found no significant difference in manipulations under anesthesia (MUA) between the 2 cohorts.
Table 1

Patient Demographics

DemographicsEarly Cohort (n = 27,057)Late Cohort (n = 27,057)P Value
Obesity5,356 (19.8%)5,356 (19.8%)1
Diabetes2,163 (7.9%)2,163 (7.9%)1
Tobacco5,761 (21.3%)5,761 (21.3%)1
>60 years old518 (1.9%)518 (1.9%)1
Female14,254 (52.7%)14,254 (52.7%)1

NOTE. n = 54,114. Patient demographics showing the percentage of patients with diagnosis of obesity, history of diabetes, history of tobacco use, age older than 60 years, and female sex in both the early (2010-2012) and late (2016-2018) cohorts.

Table 2

Complication Rates

OutcomesEarly Cohort (n = 27,057)Late Cohort (n = 27,057)P Value
Quadriceps rupture15 (0.1%)1 (0.003%)<.001
Patella tendon rupture12 (0.04%)1 (0.003%).003
Manipulation198 (0.7%)221 (0.8%).178
Adhesion lysis22 (0.08%8 (0.03%).013
Infection344 (1.3%)191 (0.7%)<.001
DVT3 (0.01%)89 (0.3%)<.001

NOTE. P values in bold indicate statistical significance.

DVT, deep vein thrombosis.

Patient Demographics NOTE. n = 54,114. Patient demographics showing the percentage of patients with diagnosis of obesity, history of diabetes, history of tobacco use, age older than 60 years, and female sex in both the early (2010-2012) and late (2016-2018) cohorts. Complication Rates NOTE. P values in bold indicate statistical significance. DVT, deep vein thrombosis. The univariate and multivariate logistic regression results are listed in Appendix Table 1, Appendix Table 2, Appendix Table 3, Appendix Table 4, Appendix Table 5, Appendix Table 6, Appendix Table 7, Appendix Table 8, available at www.arthroscopyjournal.org. Univariate analysis demonstrated QT rupture to be independently associated with diabetes (OR 5.24; 95% CI 1.65-14.4). MUA was found to be independently associated with female sex (OR 2.3; 95% CI 1.86-2.85). Patella tendon rupture and lysis of adhesions were not found to be associated with any patient comorbidities. Infection was found to be associated with female sex, obesity, and tobacco use on multivariate analysis, whereas DVT was found to associated with diabetes and obesity.
Appendix Table 1

Quadriceps Rupture Univariate Analysis

CharacteristicQuadriceps Rupture OR (95% CI)P Value
Late Cohort0.07 (0.01-0.33)<.001
Age >60 y3.42 (0.45-25.99).234
Sex (female)0.08 (0.01-0.64).477
Diabetes5.24 (1.65-14.4).002
Obesity1.36 (0.38-3.88).603
Tobacco0.85 (0.20-2.65).804

NOTE. P values in bold indicate statistical significance.

CI, confidence interval; OR, odds ratio.

Appendix Table 2

Patella Rupture Univariate Analysis

CharacteristicPatella Rupture OR (95% CI)P Value
Late cohort0.08 (0.01-0.64).017
Age >60 y1.76 (0.99-2.27).988
Sex (female)0.40 (0.13-1.30).126
Diabetes0.96 (0.12-7.38).968
Obesity0.74 (0.16-3.32).691
Tobacco2.31 (0.76-7.07).142

NOTE. P values in bold indicate statistical significance.

CI, confidence interval; OR, odds ratio.

Appendix Table 3

Manipulation Univariate Analysis

CharacteristicManipulation OR (95% CI)P Value
Late cohort1.12 (0.92-1.35).260
Age >60 y0.62 (0.26-1.49).284
Sex (female)2.30 (1.86-2.85)<.001
Diabetes1.02 (0.70-1.42).927
Obesity1.14 (0.90-1.44).265
Tobacco1.19 (0.95-1.49).126

NOTE. P values in bold indicate statistical significance.

CI, confidence interval; OR, odds ratio.

Appendix Table 4

Adhesion Lysis Univariate Analysis

CharacteristicAdhesion Lysis OR (95% CI)P Value
Late cohort0.36 (0.15-0.78).014
Age >60 y2.07 (0.34-4.38).981
Sex (female)0.69 (0.33-1.41).308
Diabetes2.26 (0.29-4.33).984
Obesity1.23 (0.49-2.73).627
Tobacco1.58 (0.69-3.36).248

NOTE. P values in bold indicate statistical significance.

CI, confidence interval; OR, odds ratio.

Appendix Table 5

Infection Univariate Analysis

CharacteristicInfection OR (95% CI)P Value
Late cohort0.55 (0.46-0.66)<.001
Age >60 y0.58 (0.23.-1.18).184
Sex (female)0.66 (0.55-0.78)<.001
Diabetes1.40 (1.07-1.85).015
Obesity1.59 (1.23-1.81)<.001
Tobacco1.66 (1.38-1.99)<.001

NOTE. P values in bold indicate statistical significance.

CI, confidence interval; OR, odds ratio.

Appendix Table 6

Infection Multivariate Analysis

CharacteristicInfection OR (95% CI)P Value
Late cohort0.49 (0.43-0.55)<.001
Sex (female)0.63 (0.56-0.71)<.001
Diabetes1.14 (0.92-1.39).213
Obesity1.34 (1.15-1.54)<.001
Tobacco1.36 (1.19-1.56)<.001

NOTE. P values in bold indicate statistical significance.

CI, confidence interval; OR, odds ratio.

Appendix Table 7

DVT Univariate Analysis

CharacteristicDVT OR (95% CI)P Value
Late cohort29.77 (9.42-94.02)<.001
Age >60 y1.14 (0.28-4.63).856
Sex (female)0.98 (0.65-1.48).922
Diabetes2.43 (1.42-4.17)<.001
Obesity2.73 (1.79-4.13)<0.001
Tobacco1.46 (0.93-2.30).104

NOTE. P values in bold indicate statistical significance.

CI, confidence interval; DVT, deep vein thrombosis; OR, odds ratio.

Appendix Table 8

DVT Multivariate Analysis

CharacteristicDVT OR (95% CI)P Value
Late cohort14.05 (8.18-26.68)<.001
Diabetes1.59 (1.02-2.39).031
Obesity2.15 (1.56-2.95)<.001

NOTE. P values in bold indicate statistical significance.

CI, confidence interval; DVT, deep vein thrombosis; OR, odds ratio.

Discussion

The most important finding of our study was that patients who underwent ACLR in the late cohort had lower rates of postoperative complications, except for DVT. Counterintuitively, there was a significantly lower number of postoperative QT ruptures in patients who underwent ACL reconstruction in the late cohort despite increasing popularity of QT autograft over the past decade. The rate of patella tendon rupture also significantly decreased in the late cohort; however, this observation may be secondary to the decreasing popularity of BPTB autograft for ACL reconstruction over the past 2 decades (preferred graft for 90% of surgeons in 1990 to under 40% in 2021)., There was a significant increase in the rate of DVTs in the late cohort. At our institution pharmacologic thromboprophylaxis is not routinely prescribed for patients following ACL reconstruction. A recent national insurance database study reported that only 3.5% of the more than 14,000 patients included in the study received pharmacologic thromboprophylaxis following ACL reconstruction. Interestingly, pharmacologic thromboprophylaxis other than aspirin (acetylsalicylic acid) was associated with increased risk of procedural intervention for arthrofibrosis after ACL reconstruction. In our study, DVT was associated with diabetes and obesity. Not using a tourniquet has also previously been reported to decrease the incidence of DVT after ACL reconstruction. Surgeons should consider forgoing or limiting the use of tourniquet in patients who are high risk for postoperative DVT (those with obesity, diabetes, or those who are smokers)., The overall infection rate was low between the 2 cohorts, approximately 1%. Infection, not surprisingly, was associated with obesity and tobacco use, which has previously been reported. Baron et al. previously demonstrated that ACL graft preparation with vancomycin-soaked grafts were associated with a 10-fold reduction in infection rate after ACL reconstruction (0.1 vs 1.2%). Graft preparation with vancomycin-soaked gauze for high-risk patients (those with obesity or those who are smokers) should be considered. The rate of return to the operating room for postoperative lysis of adhesion was found to be significantly lower in the late cohort. These findings may be secondary to the continued emphasis on the importance of prehabilitation before ACL reconstruction.18, 19, 20 Female sex was found to be associated with MUA; this risk factor has been previously described with similar ORs to our results. Interestingly there was no difference in MUA between the cohorts, despite the significant difference in lysis of adhesions. Given the increasing popularity of QT autograft for ACL reconstruction, several studies have been published recently comparing the outcomes of QT autograft with BPTB and NT autografts. Two recently published systematic reviews demonstrated QT autograft has comparable clinical and functional outcomes and graft survival rate with BPTB and HT autografts., Several studies have demonstrated significantly less harvest-site pain in patients who underwent ACL reconstruction with QT autograft compared with BPTB autograft.22, 23, 24, 25, 26 However, three studies demonstrated no significant difference in donor-site pain when comparing HT autograft to QT autograft.,, Biomechanically QT autograft has properties similar to those of the native ACL., The cross-sectional area and load to failure of the native ACL is 44 mm2 and 1725 to 2160 N, respectively. While the tensile strength of the QT autograft is 2352 N, which exceeds the load to failure of the native ACL, and is similar to the tensile strength of BPTB(2977 N) and quadriceps autograft (2422 to 4090 N). However, in comparison, the cross-sectional area of QT autograft is larger (62 mm2) than HT (53 mm2) and BPTB (35 mm2) autografts., Thus, QT autograft provides a thicker graft, compared with HT and BPTB autograft, with acceptable load to failure strength and similar clinical and functional outcomes. Both QT and BPTB autograft are harvested from the extensor mechanism; thus, potential donor-site morbidity theoretically is similar between the 2 graft choices. However, BPTB carries a greater incidence of morbidity in terms of anterior knee pain, patella fracture, patella tendon rupture, patellofemoral arthritis, kneeling pain, and infrapatellar nerve injury.,33, 34, 35, 36, 37 In their series of 5364 ACL reconstructions with BPTB autograft, Benner at al. reported an incidence of patella tendon rupture of 0.24%. In comparison with our findings, the rate of patella tendon rupture after ACL reconstruction with BPTB autograft reported by Benner et al. is approximately 1,000 times that of QT rupture following ACL reconstruction. Thus, all-soft tissue QT auto graft demonstrates a lower rate of extensor mechanism disruption when compared BPTB autograft.

Limitations

This paper has a number of limitations consistent with those of any database study. The power of this paper rests on the validity of physician billing and coding, which at times can be imprecise. Although previous studies have reported the error rate of coding to be roughly 1.3%, it is important nonetheless to acknowledge that we are unable to report the accuracy of the coding in this dataset. Unfortunately, there is only one CPT code for ACL reconstruction (29888), and it does not further specify between ACL repair, ACL reconstruction, and if reconstruction was performed whether autograft or allograft was used and the technique performed. Further, the PearlDiver database does not code for laterality, thus we were unable to confirm whether the 20 cases of QT rupture were on the ipsilateral side of the ACL reconstruction. Thus, it is likely that our findings overestimated the number of QT ruptures following ACL reconstructions, and our findings should be interpreted with this in mind.

Conclusions

Patients who underwent surgery in the late cohort had lower rates of postoperative complications, except for DVT. The rate of postoperative QT rupture decreased despite considerable increase in the use of QT autograft.
  37 in total

1.  ACL Study Group survey reveals the evolution of anterior cruciate ligament reconstruction graft choice over the past three decades.

Authors:  Markus P Arnold; Jacob G Calcei; Nicole Vogel; Robert A Magnussen; Mark Clatworthy; Tim Spalding; John D Campbell; John A Bergfeld; Seth L Sherman
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-01-24       Impact factor: 4.342

2.  Incidence of Anterior Cruciate Ligament Tears and Reconstruction: A 21-Year Population-Based Study.

Authors:  Thomas L Sanders; Hilal Maradit Kremers; Andrew J Bryan; Dirk R Larson; Diane L Dahm; Bruce A Levy; Michael J Stuart; Aaron J Krych
Journal:  Am J Sports Med       Date:  2016-02-26       Impact factor: 6.202

3.  Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis of Outcomes for Quadriceps Tendon Autograft Versus Bone-Patellar Tendon-Bone and Hamstring-Tendon Autografts.

Authors:  Dany Mouarbes; Jacques Menetrey; Vincent Marot; Louis Courtot; Emilie Berard; Etienne Cavaignac
Journal:  Am J Sports Med       Date:  2019-02-21       Impact factor: 6.202

4.  Anterior cruciate ligament reconstruction: autogenous quadriceps tendon-bone compared with bone-patellar tendon-bone grafts at 2-year follow-up.

Authors:  Sung-Jae Kim; Praveen Kumar; Kyung-Soo Oh
Journal:  Arthroscopy       Date:  2008-11-20       Impact factor: 4.772

5.  Biomechanical analysis of human ligament grafts used in knee-ligament repairs and reconstructions.

Authors:  F R Noyes; D L Butler; E S Grood; R F Zernicke; M S Hefzy
Journal:  J Bone Joint Surg Am       Date:  1984-03       Impact factor: 5.284

6.  Procedural intervention for arthrofibrosis after ACL reconstruction: trends over two decades.

Authors:  Thomas L Sanders; Hilal Maradit Kremers; Andrew J Bryan; Walter K Kremers; Michael J Stuart; Aaron J Krych
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-09-26       Impact factor: 4.342

7.  Anatomic anterior cruciate ligament (ACL) reconstruction: a global perspective. Part 1.

Authors:  K K Middleton; T Hamilton; J J Irrgang; J Karlsson; C D Harner; F H Fu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-05       Impact factor: 4.342

8.  Incidence and risk factors for symptomatic venous thromboembolism following anterior cruciate ligament reconstruction.

Authors:  Enrico M Forlenza; Kevin C Parvaresh; Matthew R Cohn; Ophelie Lavoie-Gagne; Zain M Khazi; Yining Lu; William Cregar; Brian Forsythe
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-05-10       Impact factor: 4.342

9.  Not Using a Tourniquet May Reduce the Incidence of Asymptomatic Deep Venous Thrombosis After ACL Reconstruction: An Observational Study.

Authors:  Masaki Nagashima; Kenichiro Takeshima; Nobuto Origuchi; Ryo Sasaki; Yoshifumi Okada; Toshiro Otani; Ken Ishii
Journal:  Orthop J Sports Med       Date:  2021-12-06

10.  Quadriceps tendon autograft is becoming increasingly popular in revision ACL reconstruction.

Authors:  Philipp W Winkler; Thiago Vivacqua; Stephan Thomassen; Lisa Lovse; Bryson P Lesniak; Alan M J Getgood; Volker Musahl
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-02-16       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.